четверг, 24 ноября 2011 г.

Early Childbirth Linked To Poor Health In Middle Age

Women who have their first child before age 20 are at a higher risk of chronic diseases and death when they reach middle age, a new study shows


The study appears in the September issue of the Journal of Health and Social Behavior and reveals that women who are single at the time they have their first baby could also be at risk of earlier death an outcome that can probably relates to socioeconomic status later in life after having a child as a young, single woman.


"Being unmarried at the time of first birth is associated with lower midlife income and a lower probability of being married in midlife," said study author John Henretta at the University of Florida. "It's not so much the characteristic of being unmarried at first birth that's important; it's what being unmarried at first birth tells us about the midlife status of these women."


Henretta evaluated data from the Health and Retirement Study, focusing on 4,335 women born in the United States between 1931 and 1941. These women were first interviewed in 1992 (at ages 51 to 61) and then followed until 2002. Interviewers asked about their health, level of education, marital status, wealth, how many children they had and the age of each living child.


Study data showed that women who give birth before age 20 have a risk of dying 1.42 times higher than that of women who first give birth after age 20. Women who had a child before age 20 also had higher rates of reporting having heart disease, lung disease and cancer.


Henretta said that having a baby while unmarried could lead to a lower chance of eventually marrying and lower economic status in midlife, which research shows can relate to poorer access to healthcare.


"The conditions under which a woman has a child at a young age would be important to consider," said Ken R. Smith, a professor of human development and family studies at the University of Utah. "For example, were her parents or siblings there to assist in rearing the child, did the child survive, did the mother go on to marry the father and was that first child followed quickly by another birth?


"But overall, this [study] is a plausible finding and worth replicating," Smith added. "A parallel study of men would be useful to determine if the effects exist for the fathers as well."


Henretta JC. Early childbearing, marital status, and women's health and mortality after age 50. J Health Soc Behav 48(3), 2007.


Health Behavior News Service

Center for the Advancement of Health 2000 Florida Ave. NW, Ste 210

Washington, DC 20009

United States

hbns

четверг, 17 ноября 2011 г.

NPR Broadcasts First Of Four Reports On College Rape, Sexual Assault

"Morning Edition" on Wednesday aired the first segment in a four-part series examining sexual assault and rape on U.S. college campuses. The series, which was produced in partnership with the Center for Public Integrity, focuses on the "failure" of colleges and the Department of Education "to prevent these assaults and then to resolve these cases." According to Department of Justice estimates, one of out of every five college women is sexually assaulted.

Wednesday's segment examined the effects of the Jeanne Clery Act, a crime disclosure law passed 20 years ago. According to DOJ figures, campuses have reported a 9% decrease in violent crime and a 30% decrease in property crime in the past 10 years under the Clery Act. However, DOE has fined schools that violate the act only six times, and most fines have been less than $350,000 (Shapiro, "Morning Edition," NPR, 2/24).


Reprinted with kind permission from nationalpartnership. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.


© 2010 The Advisory Board Company. All rights reserved.

четверг, 10 ноября 2011 г.

Kansas Equal Rights Amendment Proposal Prompts Criticism From Antiabortion Groups

Kansas lawmakers are considering a proposal that would place a state Equal Rights Amendment (H.R. 5003) before voters in the next general election, the Kansas City Star reports. The amendment would grant women the same rights to men in the state constitution. According to the Star, antiabortion-rights groups have suggested that an ERA could "open the door to a constitutional guarantee for abortion" in Kansas. Although Kansas does have a statute outlawing gender-based discrimination, ERA supporters maintain that the amendment could make it less difficult for women to successfully argue sexual discrimination and harassment lawsuits. They also cite the symbolic value of having equal rights for women included in the state constitution.

Catholic and antiabortion-rights groups believe that an ERA could derail all state restrictions on abortion. Beatrice Swoopes, a lobbyist with the Kansas Catholic Conference, said, "If we allow it to pass, Kansans will wake up one day wondering how a right to unrestricted and taxpayer-funded abortion was smuggled into our constitution." However, Washburn University professor Jeffrey Jackson noted that many states with ERAs have more restrictive abortion policies than Kansas.

Kansas lawmakers would have to approve the proposal by a two-thirds vote in both chambers to place the measure on the state ballot. According to the Star, the proposal "might not get that far," as state Sen. Pete Brungardt (R), who leads the committee reviewing the bill, has not decided whether the committee will have the time to vote on the legislation this year (Klepper, Kansas City Star, 2/26).


Reprinted with kind permission from nationalpartnership. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.


© 2009 The Advisory Board Company. All rights reserved.

четверг, 3 ноября 2011 г.

Insomnia In Adults Improved By A Self-Help Program Delivered Online

A cognitive behavioral intervention for insomnia delivered via the Internet can significantly improve insomnia in adults, according to a research abstract presented at SLEEP 2008, the 22nd Annual Meeting of the Associated Professional Sleep Societies (APSS).



The study, authored by Lee Ritterband, PhD, of the University of Virginia, focused on 44 participants (mostly female) with an average age of 45 years. The participants were randomly selected to either the cognitive behavioral intervention for insomnia via the Internet or a wait list control. Measures of sleep, mood, cost, and cognitive functioning were collected at pre- and post-treatment, while additional measures of sleep were collected throughout treatment.



According to the results, sleep improved significantly for those who received a cognitive behavioral intervention for insomnia via the Internet over the six-week intervention, whereas control participants showed no change during the treatment period. Sleep efficiency also significantly improved for the experimental group from pre- to post- assessment, with no change for the controls. The experimental group increased total sleep time by 80 minutes and the control group increased by nine minutes.



"We believe these types of Web-based treatment programs have the potential to impact countless individuals around the world," said Dr. Ritterband. "Specifically related to insomnia, the availability of non-pharmacological help is significantly lacking. The Internet has already become a critical source of health-care and medical information. The Internet may prove an effective tool to more broadly disseminate cognitive behavioral therapy for insomnia."



Insomnia is a classification of sleep disorders in which a person has trouble falling asleep, staying asleep or waking up too early. It is the most commonly reported sleep disorder. About 30 percent of adults have symptoms of insomnia. It is more common among elderly people and women.



Cognitive behavioral therapy (CBT) helps you change actions or thoughts that hurt your ability to sleep well. It helps you develop habits that promote a healthy pattern of sleep. CBT is most often used for people who suffer from insomnia.



The American Academy of Sleep Medicine (AASM) offers the following tips on how to get a good night's sleep:
Follow a consistent bedtime routine.


Establish a relaxing setting at bedtime.


Get a full night's sleep every night.


Avoid foods or drinks that contain caffeine, as well as any medicine that has a stimulant, prior to bedtime.


Do not bring your worries to bed with you.


Do not go to bed hungry, but don't eat a big meal before bedtime either.


Avoid any rigorous exercise within six hours of your bedtime.


Make your bedroom quiet, dark and a little bit cool.


Get up at the same time every morning.

Those who suspect that they might be suffering from insomnia, or another sleep disorder, are encouraged to consult with their primary care physician or a sleep specialist.







The annual SLEEP meeting brings together an international body of 5,000 leading researchers and clinicians in the field of sleep medicine to present and discuss new findings and medical developments related to sleep and sleep disorders.



More than 1,000 research abstracts will be presented at the SLEEP meeting, a joint venture of the AASM and the Sleep Research Society. The three-and-a-half-day scientific meeting will bring to light new findings that enhance the understanding of the processes of sleep and aid the diagnosis and treatment of sleep disorders such as insomnia, narcolepsy and sleep apnea.



SleepEducation, a patient education Web site created by the AASM, provides information about various sleep disorders, the forms of treatment available, recent news on the topic of sleep, sleep studies that have been conducted and a listing of sleep facilities.



Source: Kathleen McCann


American Academy of Sleep Medicine

четверг, 27 октября 2011 г.

How Men Might Contribute To Cancer In Women

If you're getting together with family this holiday season, you might want to spend some time talking about your medical history. Experts say by looking into your past, you might learn something about the risks you face in the future. If you do have that conversation with your family, be sure to talk to everyone. Your risks of certain cancers might come from some pretty unlikely people.


Even if it's just helping her dad do chores around the house, Janel Hall knows the importance of spending time with family. Janel has watched a grandmother and four aunts battle cancer. So when doctors told her she was almost certain to get it, she considered some dramatic steps to avoid it.


"We looked at all the options. One of the options was a complete hysterectomy and, of course, a complete mastectomy," says Janel.
That may seem drastic, but genetic tests show that Janel's odds of getting ovarian cancer are nearly 50% and her odds of getting breast cancer are nearly 90%. Given her family history, that didn't surprise Janel. What did surprise her is that it was her father who passed along the risk.


"There's been a big myth that people can't inherit breast or ovarian cancer genes from their father. And unfortunately, that's just not true," says Heather Hampel, a genetics counselor at Ohio State University's James Cancer Hospital.


Hampel says ovarian and breast cancer can be treated effectively if they are caught early. The best way to do that is to know your family history. But many women assume that those types of cancers can only come from their mother and don't realize they are at risk.


"If you can find out ahead of time that you have an increased risk of cancer, then you can do something about it. And this is a gift that older generations didn't have," says Hampel.


Jane's done something about it. She decided to have a hysterectomy to avoid ovarian cancer and is screened closely every year for breast cancer. Her sister tested negative. Though the test results were mixed, it's given their father some peace of mind.


"I think it's good because now there's less decision making when something shows up. We know that something has to be done, we can't just hope it gets better," says Janel's father, Ron Everson.


What put Janel at such a high risk is that she tested positive for the BRCA-1 and BRCA-2 genes that are linked to cancer. If there is a strong history of cancer in your family, you may want to meet with a genetic counselor like Janel's family did.

osu.edu

четверг, 20 октября 2011 г.

Romney Criticizes Obama For Support Of Sex Education For All Grades

Former Massachusetts Gov. Mitt Romney, who is running for the Republican presidential nomination, on Thursday criticized Sen. Barack Obama (Ill.), who is running for the Democratic presidential nomination, for supporting a 2003 measure in the Illinois Legislature that would have allowed age-appropriate sex education for children as young as kindergartners, the AP/ABC News reports. Obama in 2003 was a state senator and chair of a committee that approved a bill that would have changed Illinois sex education regulations to include instruction of any grade.

Obama on Tuesday at a Planned Parenthood Action Fund forum said that he considers sex education for kindergartners appropriate if it is tailored to their age level. He has said that if a kindergartner asks a question such as where babies come from, they should be told accurate information. Obama also said warning young people about inappropriate touching is an example of the type of sex education he supports, adding that he was criticized for his position on sex education during his 2004 U.S. Senate campaign as well.

"Sen. Obama is wrong if he thinks science-based sex education has any place in kindergarten," Romney said Thursday during a speech in Sparatansburg, S.C. Romney on Wednesday at a fundraising dinner in Colorado Springs, Colo., said, "How much sex education is appropriate for a five-year-old? In my mind, zero is the right number."

Obama on Thursday said, "We have to deal with a coarsening of the culture and the over-sexualization of our young people," adding, "Of course, part of the coarsening of that culture is when politicians try to demagogue issues to score cheap political points" (Davenport, AP/ABC News, 6/19).

Romney, Fred Thompson Vie for Social Conservative Support
The Los Angeles Times on Friday examined a recent "clash" between Romney and former Sen. Fred Thompson (Tenn.), who is expected to announce his candidacy for the Republican presidential nomination, over support of social conservatives. According to the Times, neither candidate is a "sure bet" with social conservatives, particularly because of abortion issues. Both Romney and Thompson have said they oppose abortion rights, but both candidates also have "mixed" records on the issue, the Times reports (Finnegan, Los Angeles Times, 7/20).


ABC News video of Romney's and Obama's remarks and expanded ABC News coverage are available online (ABC News, 7/19).

"Reprinted with permission from kaisernetwork. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at kaisernetwork/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

четверг, 13 октября 2011 г.

Clinical Trial Data Documenting Improved Menopause Symptoms

SE5-OH containing Natural S-equol, a novel soy germ-based ingredient in a supplement, improved menopausal symptoms, including significantly reducing hot flash frequency by nearly 59 percent, according to a peer-reviewed study in Japanese women. This key study was presented in an oral presentation at the North American Menopause Society (NAMS) 20th annual meeting. A second oral presentation reported peer-reviewed data that documented for the first time the pharmacokinetics, or absorption and distribution in the body, in U.S. menopausal women of S-equol when taken as a supplement using SE5-OH containing Natural S-equol. Development and ongoing research of SE5-OH containing Natural S-equol is conducted by the Saga Nutraceuticals Research Institute of Otsuka Pharmaceutical Co., Ltd. Pharmavite LLC, the makers of NatureMade® vitamins and minerals and a subsidiary of Otsuka Pharmaceutical Co., Ltd., is studying SE5-OH containing Natural S-equol in supplement form for management of menopausal symptoms.



"Natural S-equol, a soy-derived compound that is thought to interact with specific estrogen receptors, has been studied for its benefits in relieving menopausal symptoms in both U.S. and Japanese women. The data presented at NAMS adds to this research and illustrates the potential that SE5-OH containing Natural S-equol has for management of menopausal symptoms. Pharmavite LLC and Otsuka Pharmaceutical Co., Ltd. have a rigorous program, including additional clinical studies, to develop a SE5-OH containing Natural S-equol supplement," said Belinda H. Jenks, Ph.D., director of Scientific Affairs & Nutrition Education at Pharmavite LLC.



Soybeans contain a compound daidzein that certain bacteria living within the digestive tract of some individuals can metabolize, or convert, into Natural S-equol [7-hydroxy-3-(4'-hydroxyphenyl)-chroman], a compound thought to act as a selective estrogen receptor modulator (SERM). SERMs can bind to the body's receptors for estrogen, the naturally occurring female sex hormone, and Natural S-equol has a selective affinity for the estrogen receptor beta. Not everyone can produce Natural S-equol after soy consumption, as the production depends on the types of bacteria present in the large intestine and may be influenced by the amount of soy consumed. About 50 percent of Asians and 20 to 30 percent of North Americans and Europeans, who in general consume less soy than Asians, have the ability to produce equol. Studies in Japan have documented an association between milder menopausal symptoms in equol producers as compared to non-producers, but efficacy studies of S-equol, and of SE5-OH containing Natural S-equol, have been limited.



Investigational SE5-OH Containing Natural S-equol Supplement Improves Menopause Symptoms



In the study of Japanese postmenopausal women who were equol non-producers and reported at the NAMS annual meeting, a supplement whose active ingredient was SE5-OH containing Natural S-equol had significant effects on improving several menopausal symptoms.
















"Our clinical trial of SE5-OH containing Natural S-equol in Japanese post-menopausal women documented a significant reduction of their menopausal symptoms as measured in several ways, and the compound appears to have a promising future role in the management of women's menopausal symptoms," said study author Takashi Aso, M.D., Ph.D., of the Department of Obstetrics and Gynecology, Faculty of Medicine, Tokyo Medical and Dental University and past president of the Japanese Menopause Society. "Safe and effective alternatives to hormone replacement therapy are needed to help women who suffer from menopause symptoms."



In the study, women taking a daily oral dose of 10 milligrams (mg) of Natural S-equol via the supplement reduced their frequency of hot flashes by 58.7 percent after 12 weeks of treatment, significantly more than the 34.5 percent reduction experienced in women receiving a placebo (p=0.0092 ). The study's primary endpoint was individual menopause symptom scores after 12 weeks of treatment.



SE5-OH containing Natural S-equol also yielded positive improvements of other menopause symptoms, as measured by the study's several secondary endpoints, including total scores on menopausal symptom evaluations as assessed by a physician-administered 22-item menopausal symptom questionnaire and by a validated tool called the Visual Analogue Scale of five symptoms (hot flashes, sweating, light sleep insomnia, depression and shoulder muscle stiffness). Women in Japan in general experience less hot flashes than women in the United States but experience more neck and shoulder stiffness, the investigators noted.



The trial also evaluated safety and adverse treatment-related effects. No adverse events were reported in this study and the supplement was well tolerated. A complete report of the study data will be submitted for peer-review publication.



The trial, a randomized, double-blind, placebo-controlled, parallel-group study, evaluated 230 post-menopausal Japanese women aged 45 to 60 years. At enrollment, the women had at least one hot flash per day, did not produce equol after eating soy products, and did not take hormonal drugs or menopause symptom treatments. The postmenopausal enrollment criteria included estrogen levels of less than 21 picograms per milliliter (ml) and follicle stimulating hormone (FSH) values greater than 30 million international units/ml. Investigators randomized the women into two groups to receive either the placebo or the supplement, in the form of two daily tablets taken for 12 weeks.



The Natural S-equol used in this study and the pharmacokinetic study was in the form of SE5-OH containing Natural S-equol. The supplement tablets each contained 5 mg of Natural S-equol. The SE5-OH is the product of fermentation of soy germ by the bacterial strain Lactococcus garvieae 20-92 using a patented and proprietary process by the Otsuka Pharmaceutical Co., Ltd. The process results in the conversion of the daidzein to S-equol. SE5-OH is created under current Good Manufacturing Practices. Following fermentation, the bacteria undergoes heat denaturation and is deactivated. The process is designed to produce a Natural S-equol rich product, or nutraceutical ingredient.



SE5-OH Containing Natural S-equol Supplements Provide Very High Systemic Bioavailability



The S-equol in SE5-OH containing Natural S-equol supplement tablets was rapidly absorbed from the tablets and attained optimal concentrations in the blood stream, providing very high systemic bioavailability when given to healthy postmenopausal women. These findings were from a single-center, open-label, randomized, two-period crossover study conducted in white, non-Hispanic women. Bioavailability is a calculation of how much of a given dose of a test compound reaches the blood stream to circulate within the body, has a potential therapeutic effect and then is excreted in urine.



"These data are the first to report the pharmacokinetics of the S-equol when given in the SE5-OH containing Natural S-equol supplements to healthy U.S. postmenopausal women. This information is fundamental to determine the best dose of S-equol to use in the design of future clinical studies aimed at evaluating the effectiveness of S-equol in hormone-dependent conditions, such as menopause. We also documented that the SE5-OH Natural S-equol supplement offers a means of providing S-equol to those adults that do not produce it after ingestion of soy," said Kenneth D. R. Setchell, Ph.D., professor in the Division of Pathology and Laboratory Investigation, Department of Pediatrics, Cincinnati Children's Hospital Medical Center in Ohio. Dr. Setchell, an expert pharmacologist, evaluated the blinded data from the trial, which was conducted by Community Research in Cincinnati, Ohio, with support from Otsuka Pharmaceutical Development and Commercialization, Inc.



In the study, investigators randomly assigned 12 post-menopausal women, aged 48 to 65 years, to receive after fasting overnight either 10 mg or 30 mg of S-equol via SE5-OH containing Natural S-equol supplement tablets that each contained 5 mg of S-equol. Then 48 hours later, the women were switched to the other dosage. Following the 30 mg dose, the average peak plasma concentration, a calculation called Cmax, of Natural S-equol was 1,200 nanomoles per liter and was reached one hour after dosing.



Values for measures were similar for both doses of S-equol. Three of these measures included the calculation of Natural S-equol plasma concentration following each dosing, called an Area Under the Curve (AUC) calculation, and both Cmax and AUC calculated by dose. Also, S-equol from the SE5-OH containing Natural S-equol supplement was rapidly excreted in urine. The average half-life, the time for plasma concentrations to decrease by 50 percent, was eight hours but sustained concentrations were measureable through 48 hours after dosing. The fraction of the S-equol dose excreted in urine was more than 80 percent for both doses. A complete report of the study data will be submitted for peer-review publication.



Investigators determined that three of the 12 women (25 percent) were equol-producers, based on their equol levels after a soymilk challenge. This standard test for equol production in humans includes a three-day soy milk challenge followed by measures of urinary equol concentration on day four of the test. There were no observable differences in Natural S-equol pharmacokinetics between the equol-producers and non-producers in the study, the investigators note.



No serious adverse events were reported and nor were there any clinically important changes in the women's blood biochemistry, including FSH, triiodothyronine, thyroxine, and thyroid-stimulating hormone, or in hematology, urinalysis or vital signs after administration of the Natural S-equol supplements.



For this pharmacokinetics trial, the women's postmenopausal status enrollment criteria was serum estradiol values of less than 100 picomol per liter and FSH levels greater than 50 international units per liter. Participants could not take any prescription or over-the-counter estrogen, combination estrogen+progestin, or phytoestrogen products within 14 days before the Natural S-equol dosing. The women also had to abstain from consuming soy-, flax- or lignan-containing foods, beverages and supplements for seven days before the equol dosing.



Otsuka Pharmaceutical Co. Ltd. supported both studies.



Oral presentation



Pharmacokinetics of S-(-)-Equol Administered as SE5-OH Tablets to Healthy Postmenopausal Women Kenneth D. R. Setchell and Xueheng Zhao (Cincinnati Children's Hospital Medical Center and Cincinnati College of Medicine, Ohio); and Susan E. Shoaf and Karen Ragland (Global Clinical Development, Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, Md.)



Oral presentation



The Physiological Effects of Natural S-Equol Tablets on Menopausal Symptoms of Japanese Post-Menopausal Women Takeshi Aso, (Tokyo Medical and Dental University); Masahiro Nozaki (Kyushu Central Hospital, Fukuoka, Japan); Hiroaki Ohta (Tokyo Women's Medical University, Japan); and Tomomi Ueno and Shigeto Uchiyama (Saga Nutraceutical research Institute, Otsuka Pharmaceutical Co. Ltd., Japan).



Source:
Stephen McCauley


Porter Novelli


View drug information on Estradiol Transdermal System.